CPSAC
ARNA

Chas P. Smith & Associates (CPS)’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Chas P. Smith & Associates (CPS)’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-3,463
Closed -$203K – 94
2013
Q4 		$203K Buy
3,463
+2,634
+318% +$138K 0.02% 86
2013
Q3 		$44K Buy
+829
New +$55.7K 0.01% 86

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Chas P. Smith & Associates (CPS)'s ARNA Position: Q1 2014 in Review

Chas P. Smith & Associates (CPS) sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2014, closing a stake of 3,463 shares — an estimated $203K sold.

Chas P. Smith & Associates (CPS) first reported a position in ARNA in Q3 2013 and held it in 2 quarters. The position peaked at $203K in Q4 2013. 131 funds tracked by Wall St. Rank hold ARNA as of Q1 2014.

  • Chas P. Smith & Associates (CPS) reported no remaining Arena Pharmaceuticals Inc position as of Q1 2014 after selling out during the quarter.
  • Chas P. Smith & Associates (CPS) sold 3,463 Arena Pharmaceuticals Inc shares in Q1 2014, an estimated $203K.
  • Chas P. Smith & Associates (CPS) first reported a position in Arena Pharmaceuticals Inc in Q3 2013 and held it in 2 quarters.
  • Chas P. Smith & Associates (CPS)'s Arena Pharmaceuticals Inc position peaked at $203K in Q4 2013.
  • 131 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2014.

Based on Chas P. Smith & Associates (CPS)'s 13F filing for Q1 2014, filed 24 Apr 2014.